Darren S. Cline

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Burnaby
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jennifer Woo, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Darren S. Cline

Form 4 holding Director

PLIANT THERAPEUTICS, INC.

Security class
Common Stock (Right to Buy)
Shares / value
30,000
Estimated value
$55,669
Report date
05 Jun 2025
Price
$2.08
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Pyxis Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
45,867
Estimated value
$36,239
Report date
24 Mar 2026
Price
$0.9800
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

IMPEL PHARMACEUTICALS INC

Security class
Stock Option (right to buy)
Shares / value
13,222
Estimated value
Report date
16 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding U.S. Chief Commercial Officer

GW PHARMACEUTICALS PLC

Security class
Ordinary Shares
Shares / value
0
Estimated value
Report date
05 May 2021
Price
Ownership
Direct
Form 4 holding U.S. Chief Commercial Officer

GW PHARMACEUTICALS PLC

Security class
Share Options
Shares / value
0
Estimated value
Report date
05 May 2021
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Commercial Officer

Xenon Pharmaceuticals Inc.

Security class
No securities are beneficially owned.
Shares / value
0
Estimated value
Report date
23 Jun 2025
Price
Ownership
Direct

Insider Reports Filed by Darren S. Cline

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .